磷酸化间变型淋巴瘤激酶抗体

磷酸化间变型淋巴瘤激酶抗体Quantity size:

0.1ml

Concentration:

1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein 磷酸化间变型淋巴瘤激酶抗体comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small磷酸化间变型淋巴瘤激酶抗体 cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), LK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011].

磷酸化间变型淋巴瘤激酶抗体Also known as:

ALK (Phospho-Tyr1278/1282/1283); ALK (phospho-Y1278/1282/1283); p-ALK(Tyr1278/1282/1283); p-ALK(Y1278/1282/1283); ALK tyrosine kinase receptor precursor; ALK/EML4 fusion gene, included; ALK/NPM1 fusion gene, included; anaplastic lymphoma kinase (Ki-1); Anaplastic lymphoma kinase; Anaplastic lymphoma kinase Ki 1; Anaplastic lymphoma kinase Ki1; Anaplastic lymphoma kinase p80 CD 246; CD246; CD246 antigen; EC 2.7.10.1 Ki 1; Ki1; NBLST3; Tcrz; TFG/ALK; ALK_HUMAN.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Chicken, Dog, Cow, Horse, .

●

Immunogen: KLH conjugated Synthesised phosphopeptide derived from human ALK around the phosphorylation site of Tyr1278/1282/1283.

●

Predicted Molecular Weight: 174kDa.

磷酸化间变型淋巴瘤激酶抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  Flow-Cyt=1:20-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl604Mu01载脂蛋白A2(APOA2)多克隆抗体Polyclonal Antibody to Apolipoprotein A2 (APOA2)

kl604Ra01载脂蛋白A2(APOA2)多克隆抗体Polyclonal Antibody to Apolipoprotein A2 (APOA2)

kl153Hu01甲胎蛋白(αFP)多克隆抗体Polyclonal Antibody to Alpha-Fetoprotein (aFP)

kl153Mu01甲胎蛋白(αFP)多克隆抗体Polyclonal Antibody to Alpha-Fetoprotein (aFP)

kl153Ra01甲胎蛋白(αFP)多克隆抗体Polyclonal Antibody to Alpha-Fetoprotein (aFP)

kl896Hu01半胱氨酸蛋白酶抑制剂3(CST3)多克隆抗体Polyclonal Antibody to Cystatin 3 (CST3)

kl896Mu01半胱氨酸蛋白酶抑制剂3(CST3)多克隆抗体Polyclonal Antibody to Cystatin 3 (CST3)

kl896Ra01半胱氨酸蛋白酶抑制剂3(CST3)多克隆抗体Polyclonal Antibody to Cystatin 3 (CST3)

kl689Hu01降钙素原(PCT)多克隆抗体Polyclonal Antibody to Procalcitonin (PCT)

kl689Mu01降钙素原(PCT)多克隆抗体Polyclonal Antibody to Procalcitonin (PCT)

kl689Ra01降钙素原(PCT)多克隆抗体Polyclonal Antibody to Procalcitonin (PCT)

kl409Hu01血红蛋白(HB)多克隆抗体Polyclonal Antibody to Hemoglobin (HB)

kl409Mu01血红蛋白(HB)多克隆抗体Polyclonal Antibody to Hemoglobin (HB)

kl409Ra01血红蛋白(HB)多克隆抗体Polyclonal Antibody to Hemoglobin (HB)

kl409Gu01血红蛋白(HB)多克隆抗体Polyclonal Antibody to Hemoglobin (HB)